{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T03:25:55Z","timestamp":1789961155735,"version":"4.0.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,4,1]],"date-time":"2013-04-01T00:00:00Z","timestamp":1364774400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dermatologic Clinics"],"published-print":{"date-parts":[[2013,4]]},"DOI":"10.1016\/j.det.2012.12.002","type":"journal-article","created":{"date-parts":[[2013,2,1]],"date-time":"2013-02-01T07:22:16Z","timestamp":1359703336000},"page":"229-237","source":"Crossref","is-referenced-by-count":16,"title":["Pediatric Morphea"],"prefix":"10.1016","volume":"31","author":[{"given":"John C.","family":"Browning","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.det.2012.12.002_bib1","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jaad.2010.05.045","article-title":"Update on morphea: part I. Epidemiology, clinical presentation, and pathogenesis","volume":"64","author":"Fett","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.12.002_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jaad.2008.05.005","article-title":"Pediatric morphea (localized scleroderma): review of 136 patients","volume":"59","author":"Christen-Zaech","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2012.12.002_bib3","first-page":"73","article-title":"The epidemiology of morphea (localized scleroderma) in Olmsted County 1960-1993","volume":"24","author":"Peterson","year":"1997","journal-title":"J\u00a0Rheumatol"},{"issue":"3","key":"10.1016\/j.det.2012.12.002_bib4","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0889-857X(02)00010-8","article-title":"Scleroderma in children and adolescents","volume":"28","author":"Murray","year":"2002","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/j.det.2012.12.002_bib5","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1093\/rheumatology\/kei251","article-title":"Juvenile localized scleroderma: clinical and epidemiological features in 750 children. An international study","volume":"45","author":"Zulian","year":"2006","journal-title":"Rheumatology (Oxford)"},{"issue":"5","key":"10.1016\/j.det.2012.12.002_bib6","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1001\/archdermatol.2009.79","article-title":"Distinct autoimmune syndromes in morphea: a review of 245 adult and pediatric cases","volume":"145","author":"Leitenberger","year":"2009","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.12.002_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/j.1525-1470.2010.01277.x","article-title":"Morphea affecting a father and son","volume":"27","author":"Pham","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.12.002_bib8","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1093\/rheumatology\/ken405","article-title":"Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis","volume":"48","author":"Badea","year":"2009","journal-title":"Rheumatology (Oxford)"},{"issue":"9","key":"10.1016\/j.det.2012.12.002_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00066-009-2051-3","article-title":"Localized morphea\u2014a rare but significant secondary complication following breast cancer radiotherapy. Case report and review of the literature on radiation reaction among patients with scleroderma\/morphea","volume":"185","author":"Herrmann","year":"2009","journal-title":"Strahlenther Onkol"},{"issue":"5","key":"10.1016\/j.det.2012.12.002_bib10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1111\/j.1525-1470.2010.01258.x","article-title":"Localized severe scleroderma: a retrospective study of 26 pediatric patients","volume":"27","author":"Beltramelli","year":"2010","journal-title":"Pediatr Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.12.002_bib11","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1525-1470.2006.00289.x","article-title":"Deep morphea after vaccination in two young children","volume":"23","author":"Torrelo","year":"2006","journal-title":"Pediatr Dermatol"},{"issue":"6","key":"10.1016\/j.det.2012.12.002_bib12","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1111\/j.1365-2133.2007.08235.x","article-title":"Morphoea: a manifestation of infection with Borrelia species?","volume":"157","author":"Eisendle","year":"2007","journal-title":"Br J Dermatol"},{"issue":"9","key":"10.1016\/j.det.2012.12.002_bib13","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1001\/archderm.133.9.1174","article-title":"Borrelia burgdorferi DNA and Borrelia hermsii DNA are not associated with morphea or lichen sclerosus et atrophicus in the southwestern United States","volume":"133","author":"Colom\u00e9-Grimmer","year":"1997","journal-title":"Arch Dermatol"},{"issue":"10","key":"10.1016\/j.det.2012.12.002_bib14","first-page":"1213","article-title":"Treatment of morphea or localized scleroderma: review of the literature","volume":"9","author":"Vilela","year":"2010","journal-title":"J\u00a0Drugs Dermatol"},{"key":"10.1016\/j.det.2012.12.002_bib15","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.4065\/70.11.1068","article-title":"Classification of morphea (localized scleroderma)","volume":"70","author":"Peterson","year":"1995","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"10.1016\/j.det.2012.12.002_bib16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.berh.2007.09.003","article-title":"Localized scleroderma and systemic sclerosis: is there a connection?","volume":"21","author":"Gupta","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.det.2012.12.002_bib17","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1365-2133.2008.08647.x","article-title":"Linear morphoea follows Blaschko's lines","volume":"159","author":"Weibel","year":"2008","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.12.002_bib18","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.clindermatol.2006.07.004","article-title":"Systemic and localized scleroderma","volume":"24","author":"Chung","year":"2006","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.det.2012.12.002_bib19","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.jaad.2006.10.959","article-title":"En coup de sabre morphea and Parry-Romberg syndrome: a retrospective review of 54 patients","volume":"56","author":"Tollefson","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.12.002_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1177\/1534734607308731","article-title":"Disabling pansclerotic morphea of childhood poses a high risk of chronic ulceration of the skin and squamous cell carcinoma","volume":"6","author":"Wollina","year":"2007","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/j.det.2012.12.002_bib21","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s11926-004-0020-5","article-title":"Systemic manifestations in localized scleroderma","volume":"6","author":"Zulian","year":"2004","journal-title":"Curr Rheumatol Rep"},{"issue":"9","key":"10.1016\/j.det.2012.12.002_bib22","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1002\/art.21264","article-title":"Localized scleroderma in childhood is not just a skin disease","volume":"52","author":"Zulian","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.det.2012.12.002_bib23","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/rheumatology\/keh487","article-title":"Localized scleroderma is an autoimmune disorder","volume":"44","author":"Takehara","year":"2005","journal-title":"Rheumatology"},{"issue":"4","key":"10.1016\/j.det.2012.12.002_bib24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.jaad.2009.10.017","article-title":"Early localized morphea mimicking an acquired port-wine stain","volume":"64","author":"Nijhawan","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.12.002_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jaad.2010.05.046","article-title":"Update on morphea: part II. Outcome measures and treatment","volume":"64","author":"Fett","year":"2011","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2012.12.002_bib26","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0190-9622(98)70077-5","article-title":"Topical calcipotriene for morphea\/linear scleroderma","volume":"92","author":"Cunningham","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2012.12.002_bib27","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1046\/j.1525-1470.1999.99016.x","article-title":"Treatment of linear scleroderma with oral 1,25-dihydroxyvitamin D3 (calcitriol) in seven children","volume":"16","author":"Elst","year":"1999","journal-title":"Pediatr Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.12.002_bib28","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/j.1365-2133.2011.10535.x","article-title":"Relapse after systemic treatment in paediatric morphoea","volume":"166","author":"Mirsky","year":"2012","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2012.12.002_bib29","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-3476(00)90056-8","article-title":"Methotrexate and corticosteroid therapy for pediatric localized scleroderma","volume":"136","author":"Uziel","year":"2000","journal-title":"J\u00a0Pediatr"},{"issue":"1","key":"10.1016\/j.det.2012.12.002_bib30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0190-9622(98)70533-X","article-title":"Low-dose phototherapy for treatment of localized scleroderma","volume":"38","author":"Kerscher","year":"1998","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.12.002_bib31","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/j.1365-2133.2009.09438.x","article-title":"Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study","volume":"162","author":"Andres","year":"2010","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.det.2012.12.002_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1600-0781.2004.00080.x","article-title":"Suggested mechanism of action of UVA phototherapy in morphea: a molecular study","volume":"20","author":"El-Mofty","year":"2004","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"10.1016\/j.det.2012.12.002_bib33","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.jaad.2005.11.1063","article-title":"A\u00a0randomized controlled study of low-dose UVA1, medium dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma","volume":"54","author":"Kreuter","year":"2006","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.det.2012.12.002_bib34","first-page":"1298","article-title":"Imatinib mesylate reduces production of extracellular matrix and prevents development of experimental dermal fibrosis","volume":"54","author":"Distiler","year":"2006","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.det.2012.12.002_bib35","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.jaad.2008.04.034","article-title":"A\u00a0potential role for imatinib and other small molecule tyrosine kinase inhibitors in the treatment of systemic and localized sclerosis","volume":"59","author":"Bibi","year":"2008","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"5","key":"10.1016\/j.det.2012.12.002_bib36","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archderm.1994.01690050133027","article-title":"Treatment of severe forms of localized scleroderma with oral corticosteroids: follow-up study on 17 patients","volume":"130","author":"Joly","year":"1994","journal-title":"Arch Dermatol"},{"issue":"3","key":"10.1016\/j.det.2012.12.002_bib37","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2165\/00128071-200910030-00004","article-title":"Efficacy of topical tacrolimus 0.1% in active plaque morphea: randomized, double-blind, emollient-controlled pilot study","volume":"10","author":"Kroft","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"11","key":"10.1016\/j.det.2012.12.002_bib38","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1111\/j.1346-8138.2008.00552.x","article-title":"Topical tacrolimus 0.1% ointment in the treatment of localized scleroderma. An open label clinical and histological study","volume":"35","author":"Stefanaki","year":"2008","journal-title":"J\u00a0Dermatol"},{"issue":"4","key":"10.1016\/j.det.2012.12.002_bib39","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/09546630310015449","article-title":"Topical calcipotriol ointment in the treatment of morphea","volume":"14","author":"Tay","year":"2003","journal-title":"J\u00a0Dermatolog Treat"},{"issue":"6","key":"10.1016\/j.det.2012.12.002_bib40","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1067\/mjd.2000.108369","article-title":"Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma","volume":"43","author":"Hulshof","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"6 Pt 1","key":"10.1016\/j.det.2012.12.002_bib41","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0190-9622(97)80277-0","article-title":"High-dose UVA1 radiation therapy for localized scleroderma","volume":"36","author":"Stege","year":"1997","journal-title":"J\u00a0Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.det.2012.12.002_bib42","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1034\/j.1600-0781.2000.d01-1.x","article-title":"Low-dose broad-band UVA in morphea using a new method for evaluation","volume":"16","author":"El-Mofty","year":"2000","journal-title":"Photodermatol Photoimmunol Photomed"},{"issue":"3","key":"10.1016\/j.det.2012.12.002_bib43","first-page":"609","article-title":"Treatment of pediatric localized scleroderma with methotrexate","volume":"33","author":"Fitch","year":"2006","journal-title":"J\u00a0Rheumatol"}],"container-title":["Dermatologic Clinics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863512001660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0733863512001660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T21:55:29Z","timestamp":1539899729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0733863512001660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,4]]}},"alternative-id":["S0733863512001660"],"URL":"https:\/\/doi.org\/10.1016\/j.det.2012.12.002","relation":{},"ISSN":["0733-8635"],"issn-type":[{"value":"0733-8635","type":"print"}],"subject":[],"published":{"date-parts":[[2013,4]]}}}